Therapeutic natural compounds Enzastaurin and Palbociclib inhibit MASTL kinase activity preventing breast cancer cell proliferation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s12032-022-01701-3.pdf
Reference34 articles.
1. Hamidi H, Ivaska J. Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. 2018;18:533–48. https://doi.org/10.1038/s41568-018-0038-z.
2. Vigneron S, Robert P, Hached K, Sundermann L, Charrasse S, Labb´e J-C, Castro A, Lorca T. The master Greatwall kinase, a critical regulator of mitosis and meiosis. Int J Dev Biol. 2016;60:245–54.
3. Vigneron S, Gharbi-Ayachi A, Raymond AA, Burgess A, Labbé JC, Labesse G, Monsarrat B, Lorca T, Castro A. Characterization of the mechanisms controlling Greatwall activity. Mol Cell Biol. 2011;31(11):2262–75. https://doi.org/10.1128/MCB.00753-10.
4. Vera J, Lartigue L, Vigneron S, Gadéa G, Gire V, Del Rio M, et al. Greatwall promotes cell transformation by hyperactivating AKT in human malignancies. Elife. 2015;4: e10115. https://doi.org/10.7554/eLife.10115.
5. Taskinen ME, Närvä E, Conway J, Hinojosa LS, Lilla S, Mai A, De Franceschi N, Elo LL, Grosse R, Zanivan S, Norman JC, Ivaska J. MASTL promotes cell contractility and motility through kinase-independent signaling. J Cell Biol. 2020;219(6): e201906204. https://doi.org/10.1083/jcb.201906204.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification of hub genes and potential therapeutic mechanisms related to HPV positive head and neck squamous carcinoma based on full transcriptomic detection and ceRNA network construction;Gene;2024-06
2. SDDSynergy: Learning Important Molecular Substructures for Explainable Anticancer Drug Synergy Prediction;Journal of Chemical Information and Modeling;2024-04-30
3. PP2A as a potential therapeutic target for breast cancer: Current insights and future perspectives;Biomedicine & Pharmacotherapy;2024-04
4. Protein kinase inhibitors in the management of cancer: therapeutic opportunities from natural compounds;Journal of Asian Natural Products Research;2024-02-19
5. Recent advances in breast cancer cell line research;International Journal of Cancer;2024-01-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3